Announcements

Donanemab Receives FDA Approval

For full announcement, click here.

Call for 2026 Fellows

For details, click here

2025 Call for Development Projects Proposals

For details, click here.

2024-2025 Research Education Component (REC) Call

For details click here.

Grant Announcement

Incoming faculty member Dr. Andrew Kraft was awarded the 2024 Alzheimer’s Association Clinician Scientist Fellowship for his work in Evan Macosko’s laboratory. Andrew’s project, titled “Mechanisms of White Matter Injury in Alzheimer’s Disease and Mixed Dementia,” will utilize a novel spatial single-nucleus RNA sequencing platform on postmortem human tissue to examine how healthy aging, Alzheimer’s Disease and cerebral small vessel disease affect the molecular and spatial characteristics of white matter cell types in health and age-related disease.